Federal Advocacy / Issues / Legislation

Join in the effort to promote the Federal Patient Access to Pharmacist's Services.  Take action



Community pharmacy advocacy
and issues at the national level with NCPA.  Read more 



Health-system pharmacy advocacy
and issues at the federal level with  Find out more.


Click here for contact information to Montana's Congressional Delegation
Email, phone, fax and mailing address for US Representative Greg Gianforte, Senator Steve Daines and Senator Jon Tester.


NCPA’s Advocacy Report provides a weekly detailed summary of recent and breaking legislative, regulatory and state developments impacting independent community pharmacy, and NCPA efforts to effect policies to benefit its membership and the industry. The weekly report is distributed to NCPA leadership, key committees, allied organizations / stakeholders and major contributors to the NCPA LDF and PAC. 

Week Ending August 5, 2017
President’s Commission on Combating Drug Addiction Interim Report Released:  The report, attached, includes recommendations for action by the President.  The Commission recommended that the President “declare a national emergency” that would empower Cabinet members “to take bold steps” and “force Congress to focus on funding and empowering the Executive Branch even further” to deal with the loss of life associated with opioids and drug addiction. Other policy recommendations...Read the full report.  Click on the following documents that are mentioned in the report.  NCPA Federal Legislative Priority Grid July 2017 / 2017 State Wins as of July 31 / Commission Interim Report.
 

Week Ending July 29, 2017
House Ways & Means Committee Announces Initiative to Reduce Legislative & Regulatory Burdens for Medicare Providers:  This week Ways and Means Health Subcommittee Chairman Pat Tiberi (R-Ohio) announced a new initiative that aims “to deliver relief from the regulations and mandates that impede innovation, drive up costs, and ultimately stand in the way of delivering better care for Medicare beneficiaries.”  Read the full report.

Week Ending July 22, 2017
House Members Host Pharmacy Hour on the House Floor:
This week independent community pharmacy champions Reps. Doug Collins (R-Ga.), Austin Scott (R-Ga.) and Buddy Carter (R-Ga.) hosted a special order on the House floor to speak about the important role independent pharmacies play in the healthcare delivery system. Read the full report.

Week Ending July 15, 2017
Americans for Tax Reform Support Pharmacist Provider Status Legislation:  Attached is a letter from Americans for Tax Reform weighing in with strong support for HR 592,  pharmacist provider status legislation.  Read the full report.  Referenced letters:  Americans for Tax Reform  / MED Opioid Point of Sale

Week Ending July 1, 2017
MAC Update Amendment Included in House Defense Authorization Bill:  
Congressman Austin Scott (R-GA) successfully added an amendment to the defense authorization bill to ensure that MAC lists are regularly updated in the TRICARE retail pharmacy program.  Read the full report.

Week Ending June 24, 2017
Senate Releases Its Version of ACA Repeal Bill:  This bill retains the protections on pre-existing conditions and insurers would still be required to accept all consumers.  However, this legislation would allow states to waive compliance with other rules that stipulate that insurers must cover essential health benefits (one of which is prescription drugs).  Read the full report.

Week Ending June 17, 2017
Bill to Preserve Patient Access to Compounded Medications Introduced in the House:
This week Representatives Morgan Griffith (R-Va.) and Henry Cuellar (D-Texas) introduced H.R. 2871, the Preserving Patient Access to Compounded Medications Act of 2017.  Read the full report.

Week Ending June 10, 2017
NCPA Urges Key Medicaid Managed Care Rules Be Retained: In light of the fact that the Administration is currently reviewing the policies included in the final Medicaid managed care rule released last year (88 Fed. Reg. 27498, May 6, 2016), NCPA wrote the new Administrator of CMS, Seema Verma, to offer suggestions for provisions that are critical for retention and also offer one suggestion for expansion or addition. Read the full report.

Week Ending June 3, 2017
NCPA Submits Comments on CMS' Proposed Guidance on DIR Reporting:
This week submitted comments to CMS regarding their proposed guidance on how Part D plan sponsors report direct and indirect remuneration (DIR). While the proposed CMS guidance will not change existing policy with regard to DIR fees, it does have the potential to require plans to provide greater granularity to CMS on DIR amounts and the types of arrangements they put into place. CMS has responded positively...Read the full report.